Seeking Alpha

MagicDiligence's  Instablog

MagicDiligence
Send Message
MagicDiligence researches and recommends the most attractive value stock investing opportunities from Joel Greenblatt's Magic Formula Investing and similar screens. We use fundamental (and some technical) analysis to find equities of great companies with growth potential, outstanding management,... More
My company:
MagicDiligence.com
My blog:
MagicDiligence.com
  • The Barron's 500 Ranked as Magic Formula Stocks 0 comments
    May 10, 2011 12:42 PM | about stocks: APOL, OSK, BBRY, HRS, RAI, LLY, CA, ROST, ALV, GILD
    Last week two major investing publications - Forbes and Barron's - released their 2011 Top 500 lists of publicly traded companies. The biggest difference between the two lists are their ranking and inclusion criteria. While Forbes simply takes the top 500 companies by revenues, Barron's does a bit more work and ranks the stocks based on three criteria: revenue growth in 2010, 3-year average cash returns on investment, and 2010 cash returns on investment vs. the median firm. This makes Barron's list a bit more interesting and much more dynamic. Firms at the top of the list are expected to be fast growing companies that efficiently invest their capital, creating the greatest economic returns for shareholders (whether or not the stock price reflects it, yet).

    A couple of weeks ago, MagicDiligence wrote about how the Magic Formula Investing (NASDAQ:MFI) strategy could theoretically be applied to any group of stocks. This is a perfect opportunity to put that into motion. I've taken the top 100 non-financial stocks from Barron's list and ranked them by the MFI method. The result should be a list of efficient, revenue growing stocks that are also have cheap stock prices! The full ranking list can be found here.

    For the rest of this article, let's take a look at the top 10 in that list:

    TickerCompanyPriceQuarterEYMFI-ROICCRMFI
    Rank
    Barrons
    Rank
    APOLApollo Group, Inc.$40.622011-02-2826.3%151.7%1.44181
    OSKOshkosh Corporation$30.422011-03-3125.0%107.1%1.4421
    RIMMResearch In Motion Limited$44.852011-02-2821.1%96.2%2.0638
    HRSHarris Corporation$49.142011-03-3113.4%60.3%2.014107
    RAIReynolds American, Inc.$37.502011-03-319.8%124.6%1.10547
    LLYEli Lilly and Company$38.652011-03-3115.9%48.2%2.016103
    CACA Inc.$24.332010-12-319.4%116.8%1.18744
    ROSTRoss Stores, Inc.$78.982011-01-3110.2%84.7%1.51863
    ALVAutoliv Inc.$77.692010-12-3112.1%55.1%1.47989
    GILDGilead Sciences, Inc.$41.362010-12-3110.5%63.4%2.321075

    Magic Formula investors probably are not too surprised... 5 of those stocks are currently in the MFI screens, and most of the others have been in it within the past 6 months. Only 2 stocks - Oshkosh and Research in Motion - made the top 10 both by Barron's criteria and by MFI's. Additionally, one current MFI stock, Visa (NYSE:V), was #10 on Barron's list but did not rank per my calculations.

    Certainly there are reasons to be wary of some of them. Oshkosh is coming off of a huge government contract for mine resistant ATVs, and revenue is sure to drop going forward. Research In Motion, while still a growing company, has had to cut estimates this year and faces intense competition from Apple's (NASDAQ:AAPL) iPhone/iPad and numerous devices running Google's (NASDAQ:GOOG) Android operating system. Eli Lilly is facing a patent cliff from 2011-13 that threatens 40% of revenues. Reynolds pays a nice dividend and operates in an oligarchy with strong pricing power, but has few avenues for growth. So, clearly, there are reasons for some of these stocks to be cheap, but almost every stock becomes too cheap at some point. It can be argued that several of the aforementioned names may meet that description.

    The second "basket" we can put these stocks into are ones that face likely short-term problems, making them potentially interesting to value investors. For example, Apollo Group has been suffering huge enrollment declines as they transform their business ahead of government regulations, but once this transition laps over, I believe investors will find current valuation levels far too low for the amount of ongoing business.

    Lastly are the firms that just look plain undervalued, with no hugely concerning business challenges looming overhead. Gilead dominates the HIV drug space, has years of patent protections ahead, and is still growing at a slower but still healthy pace. CA is still viewed as a mainframe software company, but the truth is that the firm is investing heavily into growing sectors like software-as-a-service, security, and machine virtualization.


    Disclosure: Steve owns GILD, APOL
Back To MagicDiligence's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers

StockTalks

More »

Latest Comments


Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.